Aliskiren-containing Medications Warning and Contraindication in Patients with Diabetes or Kidney Impairement
FDA warns healthcare professionals of the possible risk from the use of aliskiren-containing medications with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney impairment because they can cause renal impairment, hypotension, and hyperkalemia. Background of Aliskiren-containing Medications Aliskiren is used in the treatment of [...]
Read more
Recent Comments